Evidence map›Paper›PMID 15953812›Full record

ReviewMolecular neurobiology2005

Mechanisms for inhibition of P2 receptors signaling in neural cells.

Fernando A González, Gary A Weisman, Laurie Erb, Cheikh I Seye, Grace Y Sun, Betty Velázquez, Melvin Hernández-Pérez, Nataliya E Chorna

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. The P2Y2 receptor mediates the epithelial injury response and cell migration.American journal of physiology. Cell physiology · 2010
    Article
  4. Review
  5. Article
  6. Article
  7. P2 receptors and neuronal injury.Pflugers Archiv : European journal of physiology · 2006
    Review
  8. Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Fernando A GonzálezDepartment of Chemistry, University of Puerto Rico, Río Piedras Campus, Puerto Rico. fgonzal@u.pracd.upr.clu.edu
Gary A Weisman
Laurie Erb
Cheikh I Seye
Grace Y Sun
Betty Velázquez
Melvin Hernández-Pérez
Nataliya E Chorna
University of Missouri · USUniversity of Puerto Rico at Río Piedras · PR

Funding

NCRR NIH HHS P20 RR-15565NIGMS NIH HHS S06 GM-08102
6 · The paper itself

Abstract

Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that cause the activation of astrocytes, little is known about the molecular mechanisms underlying the regulation of this process. Nucleotides released into the extracellular space from injured or dying neural cells can activate astrocytes via P2 nucleotide receptors. After a brief historical review and update of novel P2 receptor antagonists, this article focuses on recent advancements toward understanding molecular mechanisms that regulate G protein-coupled P2Y receptor signaling. Among P2Y receptor subtypes, the heptahelical P2Y2 nucleotide receptor interacts with vitronectin receptors via an RGD sequence in the first extracellular loop, and this interaction is required for effective signal transduction to activate mitogen-activated protein kinases ERK1/2, to mobilize intracellular calcium stores via activation of phospholipase C, protein kinase C isoforms, and to activate focal adhesion kinase and other signaling events. Ligation of vitronectin receptors with specific antibodies caused an inhibition of P2Y2 receptor-induced ERK1/2 and p38 phosphorylation and P2Y2 receptor-induced cytoskeleton rearrangement and DNA synthesis. Structure-function studies have identified agonist-induced phosphorylation of the C-terminus of the P2Y2 receptor, an important mechanism for receptor desensitization. Understanding selective mechanisms for regulating P2Y2 receptor signaling could provide novel targets for therapeutic strategies in the management of brain injury, synaptogenesis, and neurological disorders.

Indexed as

Purinergic P2 Receptor AntagonistsAnimalsBenzenesulfonatesHumansNeuronsPurinergic P2 Receptor AgonistsReceptors, Purinergic P2Signal Transduction4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate)BenzenesulfonatesPurinergic P2 Receptor AgonistsPurinergic P2 Receptor AntagonistsReceptors, Purinergic P2

Identifiers

PMID15953812
OpenAlexW1963711885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.